MAIN CONTENT
A committee vote that never happened
President Donald Trump withdrew Overton’s nomination on November 17, ahead of an anticipated November 18 vote in the Senate Health, Education, Labor and Pensions Committee, Reuters reported. Republicans held a one-seat advantage on the panel, leaving the nomination potentially vulnerable to a single defection. AP and CBS News likewise reported that uncertainty over support within the governing party contributed to the White House decision. The withdrawal prevented the committee from formally testing the depth of that opposition.
Yet the political arithmetic remains contested. Senator Bill Cassidy, a Republican physician from Louisiana who chairs the committee, said he had held productive conversations and believed Overton could win sufficient support in the committee and the full Senate. Cassidy had previously expressed serious reservations about her association with changes to childhood vaccination recommendations. The contrast between his subsequent assessment and the administration’s stated rationale underscores how nomination decisions reflect judgments about risk and timing, not simply recorded votes.
Vaccines, abortion medication and conflicting constituencies
Overton, a preventive medicine physician and deputy director of the White House Domestic Policy Council, was nominated in August after former FDA commissioner Marty Makary left office. According to people cited by Reuters, her involvement in the administration’s moves to revise childhood immunization policy troubled some senators, medical associations and career agency staff.

















